Home » ABIOMED ANNOUNCES EXPANDED REIMBURSEMENT AND DISTRIBUTION IN EUROPE FOR IMPELLA RECOVERCIRCULATORY SUPPORT SYSTEMS
ABIOMED ANNOUNCES EXPANDED REIMBURSEMENT AND DISTRIBUTION IN EUROPE FOR IMPELLA RECOVERCIRCULATORY SUPPORT SYSTEMS
Abiomed, Inc. today announced that the governmental authority for reimbursement in Germany (InEK) has granted the highest approval level available for Abiomed's IMPELLA RECOVER Devices. The new German reimbursement standard will apply to Abiomed's IMPELLA Recover LP 2.5, the IMPELLA Recover 5.0, the IMPELLA Recover RD, and the IMPELLA Recover LD which are available in Europe under the CE Mark and are investigational in the United States.
Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20060203005364&newsLang=en)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May